|
4th quarter |
|
January - December | ||||||
|
2011 |
2012 |
in € millions |
2011 |
2012 | ||||
|
|
|
|
|
| ||||
|
Continuing operations | ||||||||
|
3,549 |
3,673 |
Revenue |
14,604 |
15,390 | ||||
|
(2,261) |
(2,359) |
Cost of sales |
(9,035) |
(9,596) | ||||
|
1,288 |
1,314 |
Gross profit |
5,569 |
5,794 | ||||
|
– |
– |
Impairment |
– |
(2,106) | ||||
|
(750) |
(821) |
Selling expenses |
(2,943) |
(3,199) | ||||
|
(315) |
(359) |
General and administrative expenses |
(1,142) |
(1,277) | ||||
|
(96) |
(100) |
Research and development expenses |
(349) |
(387) | ||||
|
(20) |
(27) |
Other operating income/(expenses) |
10 |
(69) | ||||
|
107 |
7 |
Operating income |
1,145 |
(1,244) | ||||
|
(141) |
(54) |
Net financing expenses |
(336) |
(267) | ||||
|
– |
(1) |
Results from associates and joint ventures |
24 |
13 | ||||
|
(34) |
(48) |
Profit/(loss) before tax |
833 |
(1,498) | ||||
|
25 |
29 |
Income tax |
(233) |
(172) | ||||
|
(9) |
(19) |
Profit/(loss) for the period from continuing operations |
600 |
(1,670) | ||||
|
|
|
|
|
| ||||
|
Discontinued operations | ||||||||
|
(52) |
(22) |
Profit/(loss) for the period from discontinued operations |
(59) |
(436) | ||||
|
(61) |
(41) |
Profit/(loss) for the period |
541 |
(2,106) | ||||
|
|
|
|
|
| ||||
|
Attributable to | ||||||||
|
(68) |
(59) |
Shareholders of the company |
477 |
(2,169) | ||||
|
7 |
18 |
Non-controlling interests |
64 |
63 | ||||
|
(61) |
(41) |
Profit/(loss) for the period |
541 |
(2,106) | ||||
Tools:
